IRIS
ARCESE, WILLIAM
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 66.998
AS - Asia 7.540
EU - Europa 6.084
SA - Sud America 1.129
Continente sconosciuto - Info sul continente non disponibili 622
AF - Africa 111
OC - Oceania 14
Totale 82.498
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 66.764
SG - Singapore 3.538
CN - Cina 1.444
DE - Germania 1.192
RU - Federazione Russa 941
IT - Italia 934
BR - Brasile 908
UA - Ucraina 796
HK - Hong Kong 793
IE - Irlanda 712
VN - Vietnam 564
FR - Francia 341
GB - Regno Unito 338
KR - Corea 288
BD - Bangladesh 287
FI - Finlandia 241
SE - Svezia 240
JP - Giappone 172
IN - India 113
CA - Canada 106
PL - Polonia 93
AR - Argentina 85
MX - Messico 58
NL - Olanda 58
ES - Italia 41
ZA - Sudafrica 41
IQ - Iraq 40
AT - Austria 38
ID - Indonesia 30
TR - Turchia 29
UZ - Uzbekistan 28
EC - Ecuador 27
CO - Colombia 25
BE - Belgio 24
PH - Filippine 23
PK - Pakistan 23
MA - Marocco 21
MY - Malesia 20
CL - Cile 18
CR - Costa Rica 18
CZ - Repubblica Ceca 18
JM - Giamaica 18
PY - Paraguay 18
AE - Emirati Arabi Uniti 15
TH - Thailandia 15
UY - Uruguay 15
VE - Venezuela 15
EU - Europa 14
IR - Iran 14
KE - Kenya 14
SA - Arabia Saudita 14
AU - Australia 12
IL - Israele 12
PE - Perù 12
NP - Nepal 11
KZ - Kazakistan 10
LT - Lituania 10
BY - Bielorussia 9
DZ - Algeria 8
PT - Portogallo 8
TW - Taiwan 8
EG - Egitto 7
JO - Giordania 7
PA - Panama 7
TN - Tunisia 7
AL - Albania 6
CH - Svizzera 6
HN - Honduras 6
KG - Kirghizistan 6
AZ - Azerbaigian 5
BG - Bulgaria 5
BO - Bolivia 5
GR - Grecia 5
HU - Ungheria 5
RO - Romania 5
DK - Danimarca 4
SN - Senegal 4
TT - Trinidad e Tobago 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AM - Armenia 3
BB - Barbados 3
LB - Libano 3
LK - Sri Lanka 3
QA - Qatar 3
SV - El Salvador 3
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
CY - Cipro 2
DO - Repubblica Dominicana 2
EE - Estonia 2
ET - Etiopia 2
GE - Georgia 2
GT - Guatemala 2
HR - Croazia 2
KH - Cambogia 2
MD - Moldavia 2
MN - Mongolia 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
PS - Palestinian Territory 2
Totale 81.867
Salva come PNG Salva come JPEG
Città #
Wilmington 17.996
Woodbridge 17.265
Houston 16.019
Fairfield 2.123
Singapore 1.816
Ann Arbor 1.508
Ashburn 1.295
Chandler 943
San Jose 883
Seattle 816
Hong Kong 777
Cambridge 725
Jacksonville 688
Dublin 686
Beijing 612
Medford 535
Dearborn 455
Santa Clara 342
New York 311
The Dalles 268
Lawrence 253
Rome 247
Los Angeles 203
Moscow 195
Lauterbourg 185
Ho Chi Minh City 177
San Diego 151
Buffalo 141
Council Bluffs 136
Tokyo 135
Hanoi 131
Regensburg 128
Dallas 124
Mülheim 105
Milan 99
Helsinki 86
São Paulo 79
Orem 71
Zhengzhou 68
Menlo Park 62
London 60
Munich 57
Chicago 46
Norwalk 45
Kraków 42
Warsaw 41
Redwood City 40
Hefei 37
Redondo Beach 37
Atlanta 36
Falls Church 36
Guangzhou 36
Boardman 35
Nuremberg 35
University Park 34
Nanjing 33
Frankfurt am Main 32
Hangzhou 31
Toronto 30
Denver 28
Brooklyn 27
Haiphong 27
Johannesburg 27
Chennai 26
North Bergen 26
Detroit 25
Saint Petersburg 25
Seoul 25
Kunming 24
Rio de Janeiro 24
Da Nang 23
Montreal 23
Redmond 23
Belo Horizonte 22
Philadelphia 21
Phoenix 21
Brussels 20
Mountain View 20
Mumbai 20
San Francisco 20
Shanghai 19
Poplar 18
Verona 18
Jakarta 17
New Delhi 17
Tashkent 17
Brno 16
Columbus 16
San José 16
Nanchang 15
Naples 15
Baghdad 14
Bari 14
Elk Grove Village 14
Curitiba 13
Hounslow 13
Manchester 13
Ottawa 13
Palo Alto 13
Washington 13
Totale 70.383
Salva come PNG Salva come JPEG
Nome #
Unrelated cord blood transplant in children with high-risk acute lymphoblastic leukemia: a long-term follow-up 689
Toward optimization of postremission therapy for residual disease-positive patients with acute myeloid leukemia 638
Persistent risk of HBV reactivation despite extensive lamivudine prophylaxis in haematopoietic stem cell transplant recipients who are anti-HBc-positive or HBV-negative recipients with an anti-HBc-positive donor 582
Pre-transplant prognostic factors for patients with high-risk leukemia undergoing an unrelated cord blood transplantation 572
Treatment of acute graft-versus-host disease with prednisolone: significant survival advantage for day+5 responders and no advantage for nonresponders receiving anti-thymocyte globulin 538
Peripheral blood stem cell collection from G-CSF-stimulated unrelated donors for second transplant 528
Bowel ultrasonography as an aid for diagnosis of intestinal acute graft-versus-host-disease after allogeneic haematopoietic stem cell transplantation 512
A prospective molecular study of chimaerism in patients with haematological malignancies receiving unrelated cord blood or bone marrow transplants: detection of mixed chimaerism predicts graft failure with or without early autologous reconstitution in cord blood recipients 495
High levels of antiphospholipid antibodies are associated with cytomegalovirus infection in unrelated bone marrow and cord blood allogeneic stem cell transplantation 490
High expression levels of vla-4 (CD49d) on mobilised peripheral blood stem cells are associated with rapid engraftment in multiple myeloma patients receiving autologous transplant 488
Hematopoietic stem cell transplantation for adults with acute promyelocytic leukemia in the ATRA era: a survey of the European Cooperative Group for Blood and Marrow Transplantation 488
High incidence of post-transplant cytomegalovirus reactivations in myeloma patients undergoing autologous stem cell transplantation after treatment with bortezomib-based regimens: a survey from the Rome transplant network. 481
Hematopoietic, Mesenchymal, and Immune Cells Are More Enhanced in Bone Marrow than in Peripheral Blood from Granulocyte Colony-Stimulating Factor Primed Healthy Donors 479
A new system for quality control in hematopoietic progenitor cell units before reinfusion in autologous transplant 479
Splenic irradiation before hematopoietic stem cell transplantation for chronic myeloid leukemia: long-term follow-up of a prospective randomized study 471
Factors associated with outcomes of unrelated cord blood transplant: guidelines for donor choice 471
Fibrin glue for refractory hemorrhagic cystitis after unrelated marrow, cord blood, and haploidentical hematopoietic stem cell transplantation 470
Cord blood transplantation in adults with acute myeloid leukaemia. 469
ALL R-87 protocol in the treatment of children with acute lymphoblastic leukaemia in early bone marrow relapse 468
Post-transplant cyclophosphamide versus anti-thymocyte globulin as graft- versus-host disease prophylaxis in haploidentical transplant 467
A fatal case of invasive fungal sinusitis by Scopulariopsis acremonium in a bone marrow transplant recipient 466
Clinical and metabolic effects of different parenteral nutrition regimens in patients undergoing allogeneic bone marrow transplantation 464
Monitoring of KI and WU polyomaviruses in hematopoietic stem cell transplant patients 462
Cryotherapy reduces oral mucositis and febrile episodes in myeloma patients treated with high-dose melphalan and autologous stem cell transplant: a prospective, randomized study 460
3-Tesla MR spectroscopy in patients subjected to bone marrow transplantation: clinical correlations. 459
Impact of ABO incompatibility on patient outcome in haploidentical hematopoietic stem cell transplantation for acute myeloid leukemia - a report from the acute leukemia working party of the EBMT 458
Allogeneic hematopoietic stem cell transplantation in patients with diffuse large B cell lymphoma relapsed after autologous stem cell transplantation: a GITMO study 457
The policy of the Rome Transplant Network (RTN), a metropolitan (2009). The Potential Application Of The Allogeneic Transplant By The Policy Of Widespread Donor Search: An Intention-To-Treat Analysis From The Rome Transplant Network. 457
The potential role of pre-transplant HBcIgG seroposivity as predictor of clinically relevant cytomegalovirus infection in patients with lymphoma undergoing autologous hematopoietic stem cell transplantation: A study from the Rome Transplant Network 453
Excretion of the novel polyomaviruses KI and WU in the stool of patients with hematological disorders 451
Obstacles to managing chemotherapy-induced nausea and vomiting in high-dose chemotherapy with stem cell transplant 451
Factors predicting outcome after allogeneic transplant in refractory acute myeloid leukemia: a retrospective analysis of Gruppo Italiano Trapianto di Midollo Osseo (GITMO) 449
Ponatinib Induces a Persistent Molecular Response and Graft-versus-Host Disease/Graft-versus-Leukemia Effect in a Patient with Philadelphia-Positive Acute Lymphoblastic Leukemia with a T315I Mutation following Early Relapse after Allogeneic Transplant 447
The therapeutic use of cord blood 447
Histone deacetylase inhibitor valproic acid enhances the cytokine-induced expansion of human hematopoietic stem cells 441
Sezary syndrome in relapse after reduced intensity allogeneic transplant successfully treated with donor lymphocyte infusion 441
Pre-transplant manipulation processing of umbilical cord blood units: Efficacy of Rubinstein's thawing technique used in 40 transplantation procedures 441
Treatment with granulocyte colony-stimulating factor after allogeneic bone marrow transplantation for acute leukemia increases the risk of graft-versus-host disease and death: a study from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation 439
Platelet gel for treatment of mucocutaneous lesions related to graft-versus-host disease after allogeneic hematopoietic stem cell transplant 438
WHO classification and WPSS predict posttransplantation outcome in patients with myelodysplastic syndrome: a study from the Gruppo Italiano Trapianto di Midollo Osseo (GITMO) 438
Fractionated total body irradiation in allogeneic bone marrow transplantation in leukemia patients: analysis of prognostic factors and results in 136 patients 437
Thiotepa-based conditioning for allogeneic stem cell transplantation in acute lymphoblastic leukemia—A survey from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation 434
Higher incidence of relapse in patients with acute myelocytic leukemia infused with higher doses of CD34+ cells from leukapheresis products autografted during the first remission. 433
Thrombophilic screening in patients with paroxysmal nocturnal haemoglobinuria: a pilot study 433
CD34+ cell mobilization for allogeneic progenitor cell transplantation: efficacy of a short course of G-CSF 432
A comparison between allogeneic stem cell transplantation from unmanipulated haploidentical and unrelated donors in acute leukemia 432
Pre-transplant persistence of minimal residual disease does not contraindicate allogeneic stem cell transplantation for adult patients with acute myeloid leukemia 431
Stem cell transplantation for chronic myeloid leukemia in children 430
Pregnancy and secondary cancer after allogeneic bone marrow transplantation 430
Impact of conditioning intensity in T-replete haplo-identical stem cell transplantation for acute leukemia: a report from the acute leukemia working party of the EBMT 430
Transplantation of peripheral blood stem cells as compared with bone marrow from HLA-identical siblings in adult patients with acute myeloid leukemia and acute lymphoblastic leukemia 427
HLA-identical sibling allogeneic peripheral blood stem cell transplantation with reduced intensity conditioning compared to autologous peripheral blood stem cell transplantation for elderly patients with de novo acute myeloid leukemia 426
Cidofovir for BK virus-associated hemorrhagic cystitis: a retrospective study 425
Algorithm for donor selection in 2011 425
Increasing risk of relapse after allogeneic stem cell transplant for adult acute lymphoblastic leukemia in > or = 2nd complete remission induced by highly intensive chemotherapy 425
The Rome Transplant Network model compared to the Italian Bone Marrow Donor Registry activity for unrelated donor search process and transplant efficiency for hematologic malignancy 423
ABO-incompatible bone marrow transplantation: a GITMO survey of current practice in Italy and comparison with the literature 421
Cytogenetic and molecular diagnostic characterization combined to post-consolidation minimal residual disease assessment by flow-cytometry improves risk stratification in adult acute myeloid leukemia 420
Gastrointestinal surgical emergencies in patients treated for hemathological malignancies 419
Evaluation of a disease risk index for adult patients undergoing umbilical cord blood transplantation for haematological malignancies 419
Prognostic and therapeutic implications of minimal residual disease detection in acute myeloid leukemia. 418
Treatment of severe aplastic anemia with antilymphocyte globulin, cyclosporine and two different granulocyte colony-stimulating factor regimens: a GITMO prospective randomized study 418
Impact of Graft-versus-Host Disease Prophylaxis on Outcomes after Myeloablative Single-Unit Umbilical Cord Blood Transplantation 418
Effect of graft source on unrelated donor haemopoietic stem-cell transplantation in adults with acute leukaemia:a retrospective analysis. 417
Hospital cluster of HBV infection: molecular evidence of patient-to-patient transmission through lancing device 417
Early treatment of acute graft-versus-host disease with high- or low-dose 6-methylprednisolone: a multicenter randomized trial from the Italian Group for Bone Marrow Transplantation 417
Allogeneic stem cell transplantation for agnogenic myeloid metaplasia: a European Group for Blood and Marrow Transplantation, Société Française de Greffe de Moelle, Gruppo Italiano per il Trapianto del Midollo Osseo, and Fred Hutchinson Cancer Research Center Collaborative Study 416
Factors associated with outcome after cord blood transplantation in children with acute leukemia. Eurocord-Cord Blood Transplant Group 416
Standard versus alternative myeloablative conditioning regimens in allogeneic hematopoietic stem cell transplantation for high-risk acute leukemia 414
Cyclosporin A and short-term methotrexate versus cyclosporin A as graft versus host disease prophylaxis in patients with severe aplastic anemia given allogeneic bone marrow transplantation from an HLA-identical sibling: results of a GITMO/EBMT randomized trial 414
Matched and mismatched unrelated donor compared to autologous stem cell transplantation for acute myeloid leukemia in first complete remission: a retrospective, propensity score-weighted analysis from the ALWP of the EBMT 414
Relevance of bone marrow cell dose on allogeneic transplantation outcomes for patients with acute myeloid leukemia in first complete remission: results of a European survey 413
Allogeneic stem cell transplantation for patients with advanced primary cutaneous T-cell lymphoma 413
Reduced intensity allogeneic transplantation in primary cutaneous t-cell lymphomas. 410
Clinical and biological aspects of acute monocytic leukemia (a retrospective study of 29 patients) 409
Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia 409
Marrow versus peripheral blood for geno-identical allogeneic stem cell transplantation in acute myelocytic leukemia: influence of dose and stem cell source shows better outcome with rich marrow 408
Allogeneic stem cell transplant from HLA-identical sibling for chronic granulomatous disease and review of the literature 407
Minimal Residual Disease in Acute Myeloid Leukemia of Adults: Determination, Prognostic Impact and Clinical Applications 406
Umbilical Cord Blood Transplantation From Unrelated Donors In Patients With Ph-Positive Acute Lymphoblastic Leukemia. 406
Development of cellulitis caused by Aeromonas hydrophila in allogeneic hematopoietic transplantation: a case report. 405
Total parenteral nutrition enriched with glutamine and ω-3 fatty acid in adult patients undergoing autologous stem cell transplantation. 405
Monitoring of minimal residual disease in acute myeloid leukemia 403
Unrelated cord blood transplantation for childhood acute myeloid leukemia: a Eurocord Group analysis 402
A single high dose of idarubicin combined with high-dose ARA-C for treatment of first relapse in childhood 'high-risk' acute lymphoblastic leukaemia: a study of the AIEOP group 402
Involvement of central nervous system in adult patients with acute myeloid leukemia: Incidence and impact on outcome 402
High-dose therapy and autologous stem-cell transplantation in waldenstrom macroglobulinemia: the lymphoma working party of the european group for blood and marrow transplantation 402
Standard- versus high-dose lenograstim in adults with hematologic malignancies for peripheral blood progenitor cell mobilization. 401
N-acetylcysteine in the treatment of steroid-resistant acute graft-versus-host-disease: preliminary results. Gruppo Italiano Trapianto di Midollo Osseo (GITMO) 401
Assessment of donor-derived kir by sequential cDNA genotyping in non t cell depleted haploidentical stem cell transplanted patients 401
Bone mass, bone metabolism, and prevalence of spinal fractures in recipients of allogenic bone marrow transplantation for leukemia 400
HLA-C and HLA-DQB1 compatibility in unrelated cord blood transplants 400
Nonpermissive HLA-DPB1 disparity is a significant independent risk factor for mortality after unrelated hematopoietic stem cell transplantation 400
Monitoring treatment and survival in chronic myeloid leukemia. Italian Cooperative Study Group on Chronic Myeloid Leukemia and Italian Group for Bone Marrow Transplantation 400
The potential role of pre-transplant HBcIgG seroposivity as predictor of clinically relevant cytomegalovirus infection in patients with lymphoma undergoing autologous hematopoietic stem cell transplantation: A study from the Rome Transplant Network. 398
Extracorporeal photochemotherapy in the treatment of acute and chronic GvHD: experience from Rome Transplant Network 398
Management of advanced acute lymphoblastic leukemia in children and adults: results of the ALL R-87 protocol. AIEOP and GIMEMA Cooperative Groups 397
Unrelated donor marrow transplantation: an update of the experience of the Italian Bone Marrow Group (GITMO) 397
Outcome of patients activating an unrelated donor search: the impact of transplant with reduced intensity conditioning in a large cohort of consecutive high-risk patients 396
Killer Cell Immunoglobulin-Like Receptor-Ligand Matching and Outcomes after Unrelated Cord Blood Transplantation in Acute Myeloid Leukemia 394
Totale 44.110
Salva come PNG Salva come JPEG
Categoria #
all - tutte 196.128
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 196.128
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.334 0 366 110 102 66 192 140 138 143 154 168 755
2022/20232.748 352 238 134 261 170 655 325 133 213 17 189 61
2023/20241.008 99 47 78 25 101 232 57 39 28 23 16 263
2024/20255.336 170 1.243 571 316 66 225 449 212 536 582 467 499
2025/20268.238 573 501 1.069 678 698 305 1.033 966 1.044 650 370 351
2026/2027521 408 113 0 0 0 0 0 0 0 0 0 0
Totale 82.498